Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Financial Statement Analysis: Ono Pharma Co. Ltd. Consolidated Financials (FY2018), Study notes of Financial Statement Analysis

The consolidated financial statement of ono pharmaceutical co. Ltd. And its subsidiaries as of march 31, 2018. The balance sheet, showing current and non-current assets, current and non-current liabilities, and equity. The assets include cash and cash equivalents, trade and other receivables, marketable securities, inventories, property, plant, and equipment, intangible assets, investment securities, investments in associates, and other financial assets. The liabilities consist of trade and other payables, borrowings, other financial liabilities, income taxes payable, provisions, and other current and non-current liabilities.

Typology: Study notes

2021/2022

Uploaded on 09/12/2022

pauleen
pauleen 🇬🇧

3.5

(8)

211 documents

1 / 2

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Annual Flash Report (unaudited)
Fiscal Year ended March 31, 2018
Consolidated Statement of Financial Position
Ono Pharmaceutical Co., Ltd. and Consolidated Subsidiaries
Current assets
Cash and cash equivalents ¥146,323 ¥ 65,273 $ 615,781
Trade and other receivables 73,255 77,577 731,862
Marketable securities 17,560 9,670 91,230
Other financial assets 819 10,833 102,198
Inventories 25,334 31,290 295,189
Other current assets 7,742 14,821 139,817
Total current assets 271,033 209,464 1,976,077
Non-current assets
Property, plant, and equipment 83,659 94,321 889,822
Intangible assets 45,237 55,715 525,611
Investment securities 176,573 188,803 1,781,158
Investments in associates 114 116 1,096
Other financial assets 26,836 46,685 440,428
Deferred tax assets 10,739 10,192 96,153
Other non-current assets 3,271 3,929 37,067
Total non-current assets 346,428 399,761 3,771,334
Total assets ¥617,461 ¥ 609,226 $ 5,747,411
As of
March 31,
2018
Millions of yen Thousands of US$
ASSETS
As o
f
March 31,
2017
As of
March 31,
2018
pf2

Partial preview of the text

Download Financial Statement Analysis: Ono Pharma Co. Ltd. Consolidated Financials (FY2018) and more Study notes Financial Statement Analysis in PDF only on Docsity!

Annual Flash Report (unaudited)

Fiscal Year ended March 31, 2018

Consolidated Statement of Financial Position

Ono Pharmaceutical Co., Ltd. and Consolidated Subsidiaries

Current assets Cash and cash equivalents ¥ 146,323 ¥ 65,273 $ 615, Trade and other receivables 73,255 (^) 77,577 731, Marketable securities 17,560 (^) 9,670 91, Other financial assets (^819) 10,833 102, Inventories (^) 25,334 31,290 295, Other current assets 7,742 14,821 139, Total current assets (^) 271,033 209,464 1,976,

Non-current assets Property, plant, and equipment 83,659 94,321 889, Intangible assets 45,237 55,715 525, Investment securities 176,573 (^) 188,803 1,781, Investments in associates (^114) 116 1, Other financial assets 26,836 46,685 440, Deferred tax assets 10,739 10,192 96, Other non-current assets 3,271 3,929 37, Total non-current assets 346,428 399,761 3,771,

Total assets ¥ 617,461 ¥ 609,226 $ 5,747,

As of

March 31,

Millions of yen Thousands of US$

ASSETS

As of

March 31,

As of

March 31,

Current liabilities

Trade and other payables ¥ 30,905 ¥ 34,015 $ 320, Borrowings 423 392 3, Other financial liabilities 5,814 3,756 35, Income taxes payable 24,777 8,742 82, Provisions 6,086 (^) 11,696 110, Other current liabilities 14,928 9,869 93, Total current liabilities 82,933 68,469 645,

Non-current liabilities

Borrowings 542 320 3, Other financial liabilities 11 8 74 Retirement benefit liabilities 2,805 (^) 3,856 36, Provisions 30 30 283 Deferred tax liabilities 881 1,016 9, Long-term advances received 5,276 5,095 48, Other non-current liabilities 772 814 7, Total non-current liabilities (^) 10,316 11,138 105, Total liabilities 93,250 79,607 751,

Equity

Share capital 17,358 17,358 163, Capital reserves 17,144 17,175 162, Treasury shares (59,382) (^) (38,148) (359,884) Other components of equity 51,752 68,021 641, Retained earnings 492,237 459,985 4,339,

Non-controlling interests 5,101 5,228 49, Total equity 524,211 (^) 529,619 4,996,

Total liabilities and equity ¥ 617,461 ¥ 609,226 $ 5,747,

Millions of yen Thousands of US$

Equity attributable to owners of the parent company

LIABILITIES AND EQUITY

As of

March 31,

As of

March 31,

As of

March 31,